Jun 03, 2024 13:55
PMVP - PMV Pharmaceuticals, Inc
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.42 0.05 (3.27%) | --- | --- | --- | 0.04 (2.82%) | 0.03 (1.76%) | 0.05 (3.27%) | 0.05 (3.27%) |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.41
- Diluted EPS:
- -0.41
- Basic P/E:
- -3.5766
- Diluted P/E:
- -3.5766
- RSI(14) 1m:
- 58.0
- VWAP:
- 1.46
- RVol:
- 1.2094
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 1.43 -0.01 (-1.04%) | Oct 15 15:42 |
1m | Price decrease 1m | 1.43 -0.02 (-1.04%) | Oct 15 14:56 |
1m | Price increase 1m | 1.44 +0.02 (+1.41%) | Oct 15 14:18 |
1m | Price decrease 1m | 1.4 -0.02 (-1.41%) | Oct 15 14:12 |
1m | Price decrease 1m | 1.4 -0.02 (-1.58%) | Oct 15 12:49 |
Related News
May 29, 2024 11:00
May 28, 2024 13:47
Mar 18, 2024 20:01
Feb 29, 2024 21:01
Jan 18, 2024 21:01
Jan 05, 2024 21:01
Oct 16, 2023 13:35
Oct 13, 2023 17:14
Oct 12, 2023 16:30